TAP Pharmaceutical Products, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1970, the company has established itself as a leader in the development and marketing of innovative therapies, particularly in the fields of urology and oncology. TAP is renowned for its flagship product, Lupron, which has transformed the treatment landscape for prostate cancer and other hormone-related conditions. With a strong presence across North America and significant operations in various global markets, TAP Pharmaceutical Products has achieved notable milestones, including strategic partnerships that enhance its research capabilities. The company is committed to advancing patient care through its unique offerings, which combine cutting-edge science with a patient-centric approach. TAP's dedication to quality and innovation solidifies its position as a trusted name in the pharmaceutical sector.
We don't have data for TAP Pharmaceutical Products, Inc., but we can show you information about their parent organization instead.
View parent company